KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Overview Fund Activity
Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

71 hedge funds and large institutions have $750M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
71
Holders Change
-2
Holders Change %
-2.74%
% of All Funds
1.1%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.08%
New
10
Increased
25
Reduced
14
Closed
12
Calls
–
Puts
$23K
Net Calls
-$23K
Net Calls Change
-$23K

Top Buyers

1
N
1
Natixis
France
$11.9M
2
BlackRock
2
BlackRock
New York
$36.3M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$34.1M
4
State Street
4
State Street
Massachusetts
$6.89M
5
NHAS
5
Novo Holdings A/S
Denmark
$9.8M

Top Sellers

1
VA
1
VR Adviser
New York
$13.7M
2
Morgan Stanley
2
Morgan Stanley
New York
$631K
3
Millennium Management
3
Millennium Management
New York
$0
4
LGM
4
Logos Global Management
California
$0
5
DM
5
Deerfield Management
New York
$17.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
FCMI
1
Foresite Capital Management IV
California
$171M – – –
O
2
OrbiMed
New York
$68.2M – – –
RCM
3
RA Capital Management
Massachusetts
$63.7M – – –
NI
4
Nextech Invest
Switzerland
$53.3M +$53.3M +3,008,243 New
VVA
5
Vida Ventures Advisors
Massachusetts
$48.7M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$37.1M -$85.5K -4,823 -0.2%
BlackRock
7
BlackRock
New York
$36.3M +$3.06M +172,674 +9%
Vanguard Group
8
Vanguard Group
Pennsylvania
$34.1M +$1.08M +60,815 +3%
BC
9
Boxer Capital
California
$32.7M – – –
Viking Global Investors
10
Viking Global Investors
Connecticut
$32.3M – – –
Citadel Advisors
11
Citadel Advisors
Florida
$19.9M -$577K -32,569 -3%
DM
12
Deerfield Management
New York
$17.5M -$761K -42,940 -4%
FCMV
13
Foresite Capital Management V
California
$15.5M – – –
VA
14
VR Adviser
New York
$13.7M -$12.4M -700,000 -48%
N
15
Natixis
France
$11.9M +$11.9M +672,500 New
NHAS
16
Novo Holdings A/S
Denmark
$9.8M +$967K +54,600 +11%
HMC
17
Harvard Management Company
Massachusetts
$8.83M – – –
State Street
18
State Street
Massachusetts
$6.89M +$999K +56,355 +17%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$6.44M +$468K +26,410 +8%
RSCM
20
Rock Springs Capital Management
Maryland
$6.02M +$122K +6,860 +2%
Federated Hermes
21
Federated Hermes
Pennsylvania
$5.45M – – –
FCOMV
22
Foresite Capital Opportunity Management V
California
$5.17M +$5.17M +291,667 New
PHS
23
PFM Health Sciences
California
$4.68M – – –
WP
24
Woodline Partners
California
$4.61M – – –
American Century Companies
25
American Century Companies
Missouri
$3.79M +$706K +39,855 +23%
1
2 3 4